Stocks/ONCO

Create a free account to see ACCE Scores

Sign up for free to unlock scores, score breakdowns, and stock analysis.

ONCO

↓ PDF (Pro)
Onconetix Inc. Common Stock
HealthcareBiotechnologyUnited StatesNASDAQ
$0.51
-20.48%today
MKT CAP
$5M
-32.0% · 1Y
Earnings History
+39.6%
+12.2%
-138.9%
-63.2%
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Full Financials
Trailing P/E-
Forward P/E-0.5x
EV/EBITDA-
Price/Sales-
Dividend Yield-
Revenue Growth YoY-
Earnings Growth YoY-
Revenue Growth QoQ-
5y Revenue CAGR-
5y Earnings CAGR-
Gross Margin-
Operating Margin-
Net Margin-
ROE-
Debt / Equity-
Free Cash Flow-
Insider Ownership10.2%
Institutional Ownership2.7%
Short % of Float33.12%
Days to Cover0.0d
1 Week-32.9%
1 Month-
3 Months-
6 Months-
YTD-
1 Year-
3 Years-
5 Years-
vs 50-day SMA-
vs 200-day SMA-
vs 52w High-
vs 52w Low-
Insider Transactions
FilerRoleTypeSharesPriceValueDate
TARSH SIMONDirectorStock618$0.00$0.00M2025-08-15
RAMDEEN TIMOTHY R.DirectorStock618$0.00$0.00M2025-08-15
MEIER THOMAS PH.D.DirectorStock618$0.00$0.00M2025-08-15
OAKLEY ANDREW J.DirectorStock618$0.00$0.00M2025-08-15
OAKLEY ANDREW J.DirectorStock1,709$0.00$0.00M2025-03-21
Top Holders
HolderType% HeldValueΔ SharesAs of
DRW Securities, LLCinstitution0.22%$0.00B-36.81%2025-12-31
Fidelity Concord Street Trust-Fidelity Extended Market Index Fundfund0.07%$0.00B+254.16%2026-02-28
Xtx Topco Ltdinstitution0.06%$0.00B+100.00%2025-12-31
UBS Group AGinstitution0.04%$0.00B-14.18%2026-03-31
Tower Research Capital LLC (TRC)institution0.01%$0.00B+15.92%2025-12-31
Bank of America Corporationinstitution0.00%$0.00B+0.00%2025-12-31
SBI Securities Co., Ltd.institution0.00%$0.00B+287.10%2026-03-31
TickerCapScoreP/EFwd P/EEV/EBITDAROEGrossD/EDiv
PTGX
Protagonist Therapeutics Inc. Common Stock
$6.6B5------0.00%
CELC
Celcuity Inc. Common Stock
$6.7B5------0.00%
ACLX
Arcellx Inc. Common Stock
$6.7B5-------
KYMR
Kymera Therapeutics Inc. Common Stock
$7.0B-----27.1%0%5.230.00%
TECH
Bio-Techne Corp Common Stock
$7.1B3672.724.4----63.00%
HALO
Halozyme Therapeutics Inc. Common Stock
$7.9B7325.56.6----0.00%
Peers selected by sector + industry + nearest market cap. Best in column highlighted green, worst red.
Unlock Full Financials
Growth metrics, valuation multiples, and profitability ratios on Starter+.
Upgrade from $15/mo →
Growth73Value58Quality82Momentum61Total5
Score breakdown on Starter+
Upgrade →
Score History (90d)
Pro onlyUpgrade →
Updated 5/8/2026
Recent Alerts
No alerts yet for ONCO.
Want deep analysis?
This stock isn't in the ACCE researched universe. Browse 300+ stocks with full thesis, scores, and financial models.
Browse ACCE Indices →
Get the ACCE weekly digest
Index returns, picks recap, score movers - every Sunday. No fluff.